cs@prnpharma.com(877) 862-7796
Premium Rx National logo

Sanofi Pasteur Inc.

33 indexed presentations associated with this manufacturer name.

Reference only for licensed healthcare facilities. This page supports product identification and quote review, and does not imply current stock, manufacturer sponsorship, or direct purchasing status. Compare NDC listings and package configurations, then request a quote review if needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Request a Quote Review

Drug Search | Request a Quote Review

Manufacturer scope

This manufacturer reference page groups package-level listings associated with Sanofi Pasteur Inc.so healthcare teams can review package-level identifiers before narrowing into the NDC listing they need.

  • Reference listings: 33 indexed presentations.
  • Common generics: CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP, CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen.
  • Dosage forms shown: Injection and Kit.
  • Product-NDC families: 49281-0215, 49281-0400, 49281-0225, and 49281-0286.

How to use this page

Use this manufacturer view for product identification and package-level comparison, then move into the NDC row when your team needs a specific quote review.

Showing page 1 of 1
Tenivac - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL49281-0215-10CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
Tenivac - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL49281-0215-15CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
Adacel, TDaP - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL49281-0400-05CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
Adacel, TDaP - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL49281-0400-10CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
Adacel, TDaP - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL49281-0400-20CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
Diphtheria And Tetanus Toxoids Adsorbed - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 25 [Lf] / .5mL Injection 0.5 mL49281-0225-10CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 25 [Lf] / .5mLInjection
Daptacel - Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL49281-0286-01corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
Daptacel - Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL49281-0286-05corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
Daptacel - Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL49281-0286-10corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
Dengvaxia - Dengue Tetravalent Vaccine, Live Kit 1 Kit49281-0605-01Dengue Tetravalent Vaccine, Live-Kit
Quadracel - Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine 20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mL Injection 0.5 mL49281-0564-10diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mLInjection
Quadracel - Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine 20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mL Injection 0.5 mL49281-0564-15diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mLInjection
Pentacel - Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Inactivated Poliovirus And Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Kit 1 Kit49281-0511-05Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Inactivated Poliovirus And Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine-Kit
Fluzone Trivalent Northern Hemisphere - INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL49281-0425-50INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
Fluzone Trivalent Northern Hemisphere - INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL49281-0643-15INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
Fluzone High Dose Northern Hemisphere - INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .5mL; 60 ug / .5mL; 60 ug / .5mL Injection 0.5 mL49281-0125-65INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug / .5mL; 60 ug / .5mL; 60 ug / .5mLInjection
Fluzone Quadrivalent Northern Hemisphere - INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL49281-0926-50INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
Fluzone High-Dose Quadrivalent Northern Hemisphere - INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL Injection 0.7 mL49281-0226-65INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mLInjection
Fluzone Quadrivalent Northern Hemisphere - INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL49281-0541-15INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
Flublok Trivalent Northern Hemisphere - INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN 45 ug / .5mL; 45 ug / .5mL; 45 ug / .5mL Injection 0.5 mL49281-0725-10INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN45 ug / .5mL; 45 ug / .5mL; 45 ug / .5mLInjection
Menactra - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL Injection 0.5 mL49281-0589-05NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mLInjection
MenQuadfi - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL49281-0590-01NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
MenQuadfi - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL49281-0590-05NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
MenQuadfi - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL49281-0590-10NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
Ipol - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U] / .5mL; 8 [D'ag'U] / .5mL; 32 [D'ag'U] / .5mL Injection 5 mL49281-0860-10POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)40 [D'ag'U] / .5mL; 8 [D'ag'U] / .5mL; 32 [D'ag'U] / .5mLInjection
Typhim Vi - Salmonella Typhi Ty2 Vi Polysaccharide Antigen 25 ug / .5mL Injection 0.5 mL49281-0790-51Salmonella Typhi Ty2 Vi Polysaccharide Antigen25 ug / .5mLInjection
Typhim Vi - Salmonella Typhi Ty2 Vi Polysaccharide Antigen 25 ug / .5mL Injection 10 mL49281-0790-20Salmonella Typhi Ty2 Vi Polysaccharide Antigen25 ug / .5mLInjection
Diluent - Sodium Chloride 4.5 mg / .5mL Injection 0.6 mL49281-0912-05Sodium Chloride4.5 mg / .5mLInjection
Diluent - Sodium Chloride 4.5 mg / .5mL Injection 3 mL49281-0912-10Sodium Chloride4.5 mg / .5mLInjection
Tubersol - Tuberculin Purified Protein Derivative 5 [iU] / .1mL Injection 1 mL
View in Drug Shortage Index
49281-0752-21Tuberculin Purified Protein Derivative5 [iU] / .1mLInjection
Tubersol - Tuberculin Purified Protein Derivative 5 [iU] / .1mL Injection 5 mL
View in Drug Shortage Index
49281-0752-22Tuberculin Purified Protein Derivative5 [iU] / .1mLInjection
Yf-Vax - Yellow Fever Virus Strain 17D-204 Live Antigen 4.74 [PFU] / .5mL Injection 0.5 mL49281-0915-01Yellow Fever Virus Strain 17D-204 Live Antigen4.74 [PFU] / .5mLInjection
Yf-Vax - Yellow Fever Virus Strain 17D-204 Live Antigen 4.74 [PFU] / .5mL Injection 2.5 mL49281-0915-05Yellow Fever Virus Strain 17D-204 Live Antigen4.74 [PFU] / .5mLInjection

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.